Is sodium picosulfate tablets (SUB‑TAB) an appropriate colonoscopy preparation for a healthy 84‑year‑old woman with inflammatory bowel disease?

SUB-TAB (Sodium Picosulfate) Requires Caution in This 84-Year-Old Woman with IBD

I would recommend against using SUB-TAB (sodium picosulfate tablets) as first-line preparation for this patient, and instead favor a low-volume PEG-based regimen (2L PEG-ELS with ascorbate) due to significant age-related hyponatremia risk. While sodium picosulfate preparations can be effective in IBD patients, the 2025 US Multi-Society Task Force guidelines specifically highlight that patients 65 years or older face a 2.4-fold increased risk of hospitalization with hyponatremia when using sodium picosulfate 1.

Key Safety Concerns in This Patient

Age-Related Hyponatremia Risk

The most critical issue is that sodium picosulfate was associated with a higher risk of hospitalization with hyponatremia (absolute risk increase: 0.05%, 95% CI: 0.04%–0.06%; RR: 2.4,95% CI: 1.5–3.9) in patients 65 years or older 1. At 84 years old, this patient falls squarely into the high-risk category. While the absolute risk increase appears small (0.05%), this represents preventable morbidity in an elderly patient.

A large population-based study of 99,237 older adults confirmed this finding, demonstrating that sodium picosulfate led to significantly more hyponatremia than polyethylene glycol preparations 2. Importantly, while this did not translate to increased mortality or urgent neurologic complications in the population study, individual patients can experience clinically significant symptoms.

Hyperosmolar Nature and Contraindications

Sodium picosulfate + magnesium citrate is contraindicated in patients with congestive heart failure, hypermagnesemia, and severe renal impairment because of its hyperosmolar nature 1. While you describe this patient as "healthy," at 84 years old, subclinical renal impairment is common and may not be immediately apparent. The 2025 guidelines explicitly recommend against hyperosmotic regimens in individuals at risk for electrolyte disturbances 1.

Evidence in IBD Populations

The good news is that sodium picosulfate preparations have been studied in IBD patients and show comparable efficacy to other low-volume preparations 3. A 2023 randomized trial in IBD outpatients found no significant differences in bowel cleansing quality between 1L-PEG, 2L-PEG, and sodium picosulfate (all achieved adequate BBPS scores) 3. However, this study did note clinically irrelevant hyponatremia was higher in the sodium picosulfate group (p < 0.0001) 3, reinforcing the electrolyte concern even in younger IBD populations.

Recommended Alternative Approach

For this 84-year-old woman with IBD, I recommend a split-dose 2L PEG-ELS with ascorbate regimen 1. Here's why:

Superior Safety Profile in Elderly

• PEG-ELS is iso-osmolar and isotonic, making it relatively safe for patients with significant comorbidities 1
• No increased hyponatremia risk compared to sodium picosulfate
• Better suited for elderly patients who may have unrecognized renal or cardiac dysfunction

Proven Efficacy in IBD

• Low-volume (2L) PEG preparations achieve adequate bowel preparation in 84.9-89.5% of patients 1
• The 2023 IBD-specific trial showed 2L-PEG had comparable efficacy to sodium picosulfate with better complete intake rates 3
• Split-dosing improves preparation quality regardless of the agent used 1

Practical Implementation

• First dose: 1L PEG-ELS with ascorbate the evening before (e.g., 6-8 PM)
• Second dose: 1L PEG-ELS with ascorbate 4-6 hours before colonoscopy, completed at least 2 hours before procedure start 1
• Ensure adequate hydration with clear liquids between doses
• Consider low-residue diet the day before

If Sodium Picosulfate Must Be Used

If there are compelling reasons to use sodium picosulfate despite the age-related risks (e.g., patient strongly prefers tablets, prior intolerance to PEG), implement these risk mitigation strategies:

• Check baseline serum sodium and renal function before prescribing
• Emphasize strict adherence to fluid intake instructions (2L water with the 24 tablets) 1
• Consider same-day monitoring of electrolytes if patient has any symptoms
• Avoid in presence of any cardiac or renal comorbidities, even if mild
• Use split-dosing (12 tablets night before, 12 tablets morning of procedure) 1

Common Pitfalls to Avoid

1. Don't assume "healthy" means no renal impairment at age 84 - subclinical dysfunction is common and increases hyponatremia risk
2. Don't use same-day dosing for morning procedures - split-dosing is superior for preparation quality 1
3. Don't overlook the IBD diagnosis - while sodium picosulfate works in IBD, the age factor takes precedence in risk stratification 3, 4
4. Don't forget that tolerability doesn't equal safety - patients may prefer sodium picosulfate tablets 3, 5, but preference shouldn't override safety concerns in high-risk elderly patients

Bottom Line

The 2025 guidelines provide a strong recommendation to select bowel preparation regimens that consider the individual's medical history and recommend against hyperosmotic regimens in individuals at risk for electrolyte disturbances 1. At 84 years old, this patient's age alone places her at significantly increased risk for hyponatremia with sodium picosulfate. While SUB-TAB is FDA-approved and effective 1, a 2L PEG-based split-dose regimen offers comparable efficacy in IBD patients with a superior safety profile for elderly individuals.